Detalhe da pesquisa
1.
Real world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group.
Gynecol Oncol
; 184: 24-30, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38277918
2.
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial.
Lancet Oncol
; 22(2): 267-276, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539744
3.
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study.
Int J Gynecol Cancer
; 31(7): 1031-1036, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33990353
4.
Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial.
Int J Gynecol Cancer
; 31(10): 1348-1355, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34462317
5.
Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study.
Int J Gynecol Cancer
; 31(6): 875-882, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33931498
6.
Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study.
Breast Cancer Res Treat
; 182(2): 401-409, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32500397
7.
Olaparib as maintenance therapy in patients with BRCA 1-2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome.
Gynecol Oncol
; 156(1): 38-44, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31699415
8.
Endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: extending endocrine sensitivity.
Future Oncol
; 16(5): 129-145, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31849236
9.
Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel.
Support Care Cancer
; 28(5): 2435-2442, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32048043
10.
The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer.
Gynecol Oncol
; 153(3): 535-540, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30979589
11.
Systemic treatment of malignant gastrointestinal neuroectodermal tumour after childhood neuroblastoma: chemotherapy in malignant gastrointestinal neuroectodermal tumour.
Anticancer Drugs
; 30(9): 959-963, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31517734
12.
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial.
Lancet Oncol
; 19(4): 474-485, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29482983
13.
It is no longer the time to disregard thyroid metastases from breast cancer: a case report and review of the literature.
BMC Cancer
; 18(1): 146, 2018 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29409458
14.
Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis.
BMC Cancer
; 16: 375, 2016 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27377827
15.
Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy.
Breast Cancer Res Treat
; 154(1): 127-32, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26424165
16.
Bone involvement by adenocarcinoma of the uterine cervix: a rare entity.
Pol J Radiol
; 80: 81-4, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25745521
17.
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.
Lancet Oncol
; 15(4): 396-405, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24582486
18.
Unexpected ovarian activity in premenopausal breast cancer survivors treated with exemestane and GnRH analogues.
Breast J
; 25(6): 1310-1311, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31338934
19.
Recurrent granulosa cell tumors (GCTs) of the ovary: a MITO-9 retrospective study.
Gynecol Oncol
; 130(1): 38-42, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23623833
20.
Tumor segmentation analysis at different post-contrast time points: A possible source of variability of quantitative DCE-MRI parameters in locally advanced breast cancer.
Eur J Radiol
; 126: 108907, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32145597